ClinicalTrials.Veeva

Menu

Study on the Role of Gamma Delta T Cells in Sepsis Immunosuppression and Its Molecular Mechanism

S

Sichuan University

Status

Completed

Conditions

Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT02361970
Sepsis-kyan0127

Details and patient eligibility

About

The purpose of the study is to evaluate the status and function of gamma delta T cells in peripheral blood of sepsis patients.

Full description

Sepsis therapy is a prominent problem of the modern critical care medicine,and improving the level of sepsis treatment by immune intervention measures is a hot research topic with close attention.Gamma delta T cells is considered as one new T lymphocyte subset in recent years,which playing an important role in resistance to infection,anti-tumor and immune regulating function in the body.First,we played attention to the status and function of gamma delta T cells in peripheral blood of sepsis patients including differentiation marker,subtype and production of related cytokine,and then the molecular mechanism of insufficient gamma delta T cells.At the same time the responsibility of gamma delta T cells of sepsis patients to certain bacteria and viral antigen and the regulation of gamma delta T cells on other natural immune cells including NK cells and mononuclear cells were studied to identify the status and role gamma delta T cells in sepsis immunosuppression by culture in vitro.Further we studied the effect of specific stimulants on proliferation and activation of gamma delta T cells in patients with sepsis and also anti-infection acquired by gamma delta T cells,expecting as an entry point to explore new treatment strategy to sepsis.

Enrollment

84 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • clinical symptoms of severe sepsis and septic shock
  • age over 18 years

Exclusion criteria

  • preexisting autoimmune disease
  • patients received immuno-suppressive treatment in the previous 6 months
  • patients with chronic infection,e.g.tuberculosis,hepatitis or HIV infection,etc.
  • pregnancy

Trial design

84 participants in 3 patient groups

severe sepsis and septic shock
Description:
patients were diagnosed severe sepsis or septic shock
patient control
Description:
Patients after elective surgeries presented with SIRS but without sepsis
volunteer
Description:
Health persons

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems